Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-16-012794
Filing Date
2016-05-02
Accepted
2016-05-02 16:07:38
Documents
67
Period of Report
2016-01-31

Document Format Files

Seq Description Document Type Size
1 10-K a2228403z10-k.htm 10-K 1260563
2 EX-4.3 a2228403zex-4_3.htm EX-4.3 164712
3 EX-10.13 a2228403zex-10_13.htm EX-10.13 62424
4 EX-21.1 a2228403zex-21_1.htm EX-21.1 2281
5 EX-23.1 a2228403zex-23_1.htm EX-23.1 2752
6 EX-31.1 a2228403zex-31_1.htm EX-31.1 8166
7 EX-31.2 a2228403zex-31_2.htm EX-31.2 8159
8 EX-32.1 a2228403zex-32_1.htm EX-32.1 5481
15 G375170.JPG g375170.jpg GRAPHIC 1051
  Complete submission text file 0001047469-16-012794.txt   7008878

Data Files

Seq Description Document Type Size
9 EX-101.INS bpmx-20160131.xml EX-101.INS 1632146
10 EX-101.SCH bpmx-20160131.xsd EX-101.SCH 41892
11 EX-101.CAL bpmx-20160131_cal.xml EX-101.CAL 58207
12 EX-101.DEF bpmx-20160131_def.xml EX-101.DEF 234831
13 EX-101.LAB bpmx-20160131_lab.xml EX-101.LAB 425058
14 EX-101.PRE bpmx-20160131_pre.xml EX-101.PRE 387329
Mailing Address 1098 HAMILTON COURT MENLO PARK CA 94025
Business Address 1098 HAMILTON COURT MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

EIN.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 10-K | Act: 34 | File No.: 001-37411 | Film No.: 161611718
SIC: 2834 Pharmaceutical Preparations